Pathogenic variants identified in PAH predict loss-of-function due to haploinsufficiency, in turn impacting SOX17-related pathways such as Wnt/β-catenin and Notch signalling 43, 44. This evidence concerns the gene SOX17 and pulmonary arterial hypertension.